The United Laboratories ULIHF Stock
The United Laboratories Price Chart
The United Laboratories ULIHF Financial and Trading Overview
| The United Laboratories stock price | 1.24 USD |
| Previous Close | 1.24 USD |
| Open | 1.3 USD |
| Bid | 1.07 USD x 30000 |
| Ask | 1.85 USD x 30000 |
| Day's Range | 1.3 - 1.3 USD |
| 52 Week Range | 1.18 - 2.28 USD |
| Volume | 1K USD |
| Avg. Volume | 295 USD |
| Market Cap | 2.81B USD |
| Beta (5Y Monthly) | 0.345 |
| PE Ratio (TTM) | 8.125 |
| EPS (TTM) | 0.16 USD |
| Forward Dividend & Yield | 0.06 (4.86%) |
| Ex-Dividend Date | July 7, 2026 |
| 1y Target Est | N/A |
ULIHF Valuation Measures
| Enterprise Value | -3086041856 USD |
| Trailing P/E | 8.125 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.21257322 |
| Price/Book (mrq) | 0.9977817 |
| Enterprise Value/Revenue | -0.234 |
| Enterprise Value/EBITDA | -1.089 |
Trading Information
The United Laboratories Stock Price History
| Beta (5Y Monthly) | 0.345 |
| 52-Week Change | -12.98% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 2.28 USD |
| 52 Week Low | 1.18 USD |
| 50-Day Moving Average | 1.3 USD |
| 200-Day Moving Average | 1.74 USD |
ULIHF Share Statistics
| Avg. Volume (3 month) | 295 USD |
| Avg. Daily Volume (10-Days) | 300 USD |
| Shares Outstanding | 1.97B |
| Float | 1.12B |
| Short Ratio | N/A |
| % Held by Insiders | 43.17% |
| % Held by Institutions | 20.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.42 |
| Trailing Annual Dividend Yield | 33.87% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.39810002 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 15.79% |
| Operating Margin (ttm) | -0.49% |
| Gross Margin | 41.74% |
| EBITDA Margin | 21.45% |
Management Effectiveness
| Return on Assets (ttm) | 4.89% |
| Return on Equity (ttm) | 13.04% |
Income Statement
| Revenue (ttm) | 13.21B USD |
| Revenue Per Share (ttm) | 7.01 USD |
| Quarterly Revenue Growth (yoy) | -13.50% |
| Gross Profit (ttm) | 5.51B USD |
| EBITDA | 2.83B USD |
| Net Income Avi to Common (ttm) | 2.09B USD |
| Diluted EPS (ttm) | 0.16 |
| Quarterly Earnings Growth (yoy) | -83.59% |
Balance Sheet
| Total Cash (mrq) | 10.61B USD |
| Total Cash Per Share (mrq) | 5.38 USD |
| Total Debt (mrq) | 4.99B USD |
| Total Debt/Equity (mrq) | 28.56 USD |
| Current Ratio (mrq) | 1.832 |
| Book Value Per Share (mrq) | 1.3028902 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.75B USD |
| Levered Free Cash Flow (ttm) | 1.03B USD |
Profile of The United Laboratories
| Country | United States |
| State | N/A |
| City | Yuen Long |
| Address | 6 Fuk Wang Street |
| ZIP | N/A |
| Phone | 852 2687 1033 |
| Website | https://tul.com.cn |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 18000 |
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-infection, and other human-used finished products, including ophthalmic drugs, topical dermatological drugs, etc.; and health and wellness products, such as general dietary supplements, healthcare food products, cross-border nutritional supplements, and medical and aesthetic skincare products for various categories comprising bone and joint nutrition, intestinal regulation, cardiovascular health, vision protection, and immunity enhancement. Further, it is involved in the research and development, production, sale, and technical services of economic and companion animal medicines for livestock, poultry, and aquatic products and pets. The company has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally. The United Laboratories International Holdings Limited was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
Q&A For The United Laboratories Stock
What is a current ULIHF stock price?
The United Laboratories ULIHF stock price today per share is 1.24 USD.
How to purchase The United Laboratories stock?
You can buy ULIHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for The United Laboratories?
The stock symbol or ticker of The United Laboratories is ULIHF.
Which industry does the The United Laboratories company belong to?
The The United Laboratories industry is Drug Manufacturers - Specialty & Generic.
How many shares does The United Laboratories have in circulation?
The max supply of The United Laboratories shares is 2.16B.
What is The United Laboratories Price to Earnings Ratio (PE Ratio)?
The United Laboratories PE Ratio is 7.75000000 now.
What was The United Laboratories earnings per share over the trailing 12 months (TTM)?
The United Laboratories EPS is 0.16 USD over the trailing 12 months.
Which sector does the The United Laboratories company belong to?
The The United Laboratories sector is Healthcare.